Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Carole Leroy"'
Autor:
Che Serguera, Lev Stimmer, Claire-Maelle Fovet, Philippe Horellou, Vanessa Contreras, Nicolas Tchitchek, Julie Massonneau, Carole Leroy, Audrey Perrin, Julien Flament, Philippe Hantraye, Joanna Demilly, Romain Marignier, Pascale Chrétien, Bert‘t Hart, Jean Boutonnat, Clovis Adam, Roger Le-Grand, Kumaran Deiva
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Abstract Background Autoantibodies against myelin oligodendrocyte glycoprotein (anti-MOG-Abs) occur in a majority of children with acquired demyelinating syndromes (ADS) and physiopathology is still under investigation. As cynomolgus macaques immuniz
Externí odkaz:
https://doaj.org/article/e1038794ee40410a885a01b24354e627
Autor:
Philippe Horellou, Aliénor de Chalus, Laetitia Giorgi, Carole Leroy, Pascale Chrétien, Salima Hacein-Bey-Abina, Christine Bourgeois, Xavier Mariette, Ché Serguera, Roger Le Grand, Kumaran Deiva
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundMyelin oligodendrocytes glycoprotein (MOG) antibody-associated disease (MOGAD) represent 25% of pediatric acquired demyelinating syndrome (ADS); 40% of them may relapse, mimicking multiple sclerosis (MS), a recurrent and neurodegenerative A
Externí odkaz:
https://doaj.org/article/ad8652ab093d42bda4c0be6345f30bc4
Autor:
Claire-Maëlle Fovet, Lev Stimmer, Vanessa Contreras, Philippe Horellou, Audrey Hubert, Nabila Seddiki, Catherine Chapon, Sabine Tricot, Carole Leroy, Julien Flament, Julie Massonneau, Nicolas Tchitchek, Bert A. 't Hart, Sandra Zurawski, Peter Klucar, Philippe Hantraye, Kumaran Deiva, Gerard Zurawski, SangKon Oh, Roger Le Grand, Ché Serguera
Publikováno v:
EBioMedicine, Vol 47, Iss , Pp 492-505 (2019)
Background: Autoimmune demyelinating diseases (ADD) are a major cause of neurological disability due to autoreactive cellular and humoral immune responses against brain antigens. A cure for chronic ADD could be obtained by appropriate immunomodulatio
Externí odkaz:
https://doaj.org/article/8dcb23ba52be4f9b83ca67c40e294427
Autor:
Philippe Horellou, Lorraine Flet-Berliac, Carole Leroy, Laetitia Giorgi, Candie Joly, Delphine Desjardins, Pascale Chrétien, Salima Hacein-Bey-Abina, Roger Le Grand, Kumaran Deiva
Publikováno v:
Brain Communications. 5
Acquired demyelinating syndrome associated with myelin oligodendrocyte glycoprotein antibodies, named recently myelin oligodendrocyte glycoprotein-associated disease, represents >27% of this paediatric syndrome. Relapses occur in 40% of them, which m
Autor:
Caroline Sevin, Béatrice Husson, Mohammed Lali, Silvia Napuri, Clovis Adam, Elise Yazbeck, Philippe Horellou, Kumaran Deiva, Carole Leroy, Hélène Maurey
Publikováno v:
Neuropediatrics. 52:337-340
Acquired demyelinating syndromes (ADS) are frequently associated with myelin oligodendrocytes glycoprotein (MOG) antibodies in children. Clinical phenotypes are heterogeneous and may delay the diagnosis, especially when they relapse and are atypical,
Autor:
Joanna Demilly, Julie Massonneau, Romain Marignier, Roger LeGrand, Jean Boutonnat, Philippe Hantraye, Bert A. 't Hart, Nicolas Tchitchek, Audrey Perrin, Julien Flament, Ché Serguera, Vanessa Contreras, Carole Leroy, Lev Stimmer, Claire-Maëlle Fovet, Pascale Chrétien, Philippe Horellou, Kumaran Deiva, Clovis Adam
Publikováno v:
Journal of Neuroinflammation
Journal of Neuroinflammation, 2019, 16, pp.244. ⟨10.1186/s12974-019-1637-7⟩
Journal of neuroinflammation, 16(1):244. BMC
Journal of Neuroinflammation, BioMed Central, 2019, 16 (1), pp.244. ⟨10.1186/s12974-019-1637-7⟩
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Journal of Neuroinflammation, 2019, 16, pp.244. ⟨10.1186/s12974-019-1637-7⟩
Journal of neuroinflammation, 16(1):244. BMC
Journal of Neuroinflammation, BioMed Central, 2019, 16 (1), pp.244. ⟨10.1186/s12974-019-1637-7⟩
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Background Autoantibodies against myelin oligodendrocyte glycoprotein (anti-MOG-Abs) occur in a majority of children with acquired demyelinating syndromes (ADS) and physiopathology is still under investigation. As cynomolgus macaques immunized with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a1f4346110a959126490ae7f9924d5
https://cea.hal.science/cea-02397764/document
https://cea.hal.science/cea-02397764/document
Targeting MOG to skin macrophages prevents EAE in macaques through TGFβ-induced peripheral tolerance
Autor:
Bert A. 't Hart, Peter Klucar, Audrey Hubert, Carole Leroy, Sabine Tricot, Julie Massonneau, Gerard Zurawski, Claire Maelle Fovet, Sandra Zurawski, Philippe Horellou, Kumaran Deiva, Catherine Chapon, Nabila Sediki, Roger Le Grand, Julien Flament, Vanessa Contreras, Che Serguera, Sangkon Oh, Nicolas Tchitchek, Lev Stimmer
To study the effect of vaccination on tolerization to the myelin antigen MOG we used a macaque model of experimental autoimmune encephalitis (EAE) in which immunization with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) elicits brain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b833d9edaa88455dd62cb1ada93e3985
Autor:
Cyrielle Bouteloup, Lorenzo Galluzzi, Marie Scoazec, Marie Sebert, Guido Kroemer, Elodie Lainey, Carole Leroy, Sylvain Thepot, Pierre Fenaux, Stéphane de Botton
Publikováno v:
Cell Cycle. 11:4079-4092
Erlotinib was originally developed as an epidermal growth factor receptor (EGFR)-specific inhibitor for the treatment of solid malignancies, yet also exerts significant EGFR-independent antileukemic effects in vitro and in vivo. The molecular mechani
Autor:
Simone Boehrer, Marie Sebert, Virginie Eclache, Lorenzo Galluzzi, Carole Leroy, Guido Kroemer, Maximilien Tailler, Sylvain Thepot, Thomas Cluzeau, Hervé Roudot, Lionel Ades, Claude Gardin, Pierre Fenaux, Fanny Baran-Marszak, Stéphane de Botton, Patrick Auberger, Elodie Lainey
Publikováno v:
Cell Cycle; Vol 10
The deregulation of the DNA damage response (DDR) can contribute to leukemogenesis and favor the progression from myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML). Since hypomethylating agent, notably azacitidine, constitute an efficien
Autor:
Cécile Goujard, Carole Leroy, Agathe Rami, Camille Lécuroux, André Cabié, Rémonie Seng, Laurence Meyer, Evguenia Krastinova, Alain Venet
Publikováno v:
The Journal of infectious diseases. 212(6)
The soluble CD14 (sCD14) level was found associated with mortality during the chronic phase of human immunodeficiency virus (HIV) infection. Here we assessed its prognostic value in 138 patients with primary HIV infection. Higher sCD14 levels were as